Trials that use: Intention-to-treat analysis
New to this method? Read the tutorial →
7,779 results
- ADJUNCT ONE™Complete statistical analysis of the phase 3 ADJUNCT ONE™ trial of liraglutide as adjunct therapy to insulin in type 1 diabetes, including non-inferiority analysis of HbA1c, body-weight and insulin-dose results, hypoglycemia, methodology,…
- Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy: Complete Statistical AnalysisIndependent statistical analysis of Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Adjuvant Chemoradiation With Weekly Oxaliplatin in Resected Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Adjuvant Chemoradiation With Weekly Oxaliplatin in Resected Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Adjuvant Dabrafenib (GSK2118436) in Patients With Surgically Resected AJCC Stage IIIC Melanoma Characterized by a BRAFV600E/K Mutation: Complete Statistical AnalysisIndependent statistical analysis of Adjuvant Dabrafenib (GSK2118436) in Patients With Surgically Resected AJCC Stage IIIC Melanoma Characterized by a BRAFV600E/K Mutation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Adjuvant Intraperitoneal Gemcitabine for Resectable Pancreatic Adenocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of Adjuvant Intraperitoneal Gemcitabine for Resectable Pancreatic Adenocarcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01206296).
- Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Elderly Patients With First Line Acute Lymphoblastic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Elderly Patients With First Line Acute Lymphoblastic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Administration of IV Laronidase Post Bone Marrow Transplant in Hurler: Complete Statistical AnalysisIndependent statistical analysis of Administration of IV Laronidase Post Bone Marrow Transplant in Hurler: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01173016).
- ADmIReIndependent statistical analysis of A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03831191).
- Adolescents’ Well-being in Community-based Treatment Versus Residential Treatment: Complete Statistical AnalysisIndependent statistical analysis of Adolescents' Well-being in Community-based Treatment Versus Residential Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06498427).
- Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ADORE BRAINIndependent statistical analysis of Brain Health in Midlife: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06640842).
- ADRD-PCIndependent statistical analysis of Palliative Care for Persons With Late-stage Alzheimer's and Related Dementias and Their Caregivers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa: Complete Statistical AnalysisIndependent statistical analysis of Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00310791).
- Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Adrenocorticotropic Hormone Stimulation in Postural Orthostatic Tachycardia Syndrome (POTS): Complete Statistical AnalysisIndependent statistical analysis of Adrenocorticotropic Hormone Stimulation in Postural Orthostatic Tachycardia Syndrome (POTS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01764711).
- Adult Study / OROS Methylphenidate Hydrochloride (HCL) (OROS MPH) in Adults With Attention Deficit Hyperactivity Disorder (ADHD): Complete Statistical AnalysisIndependent statistical analysis of Adult Study / OROS Methylphenidate Hydrochloride (HCL) (OROS MPH) in Adults With Attention Deficit Hyperactivity Disorder (ADHD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ADVANCEIndependent statistical analysis of the phase 3 ADVANCE trial of peginterferon beta-1a versus placebo in relapsing multiple sclerosis, covering negative binomial rate ratios for annualized relapse rate, Cox hazard ratios, lesion mean…
- ADVANCEIndependent statistical analysis of Assessing Diagnostic Value of Non-invasive FFRCT in Coronary Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02499679).
- Advance Cardiac Resynchronization Therapy (CRT) Registry: Complete Statistical AnalysisIndependent statistical analysis of Advance Cardiac Resynchronization Therapy (CRT) Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01805154).
- Advance Care Planning Impact on the Consistency of Older Adults With Lung Cancer and Their Potential Surrogates Regarding Life-Sustaining Treatment Preferences: Complete Statistical AnalysisIndependent statistical analysis of Advance Care Planning Impact on the Consistency of Older Adults With Lung Cancer and Their Potential Surrogates Regarding Life-Sustaining Treatment Preferences: primary endpoint results, effect estimate with confidence…
- ADvantageIndependent statistical analysis of A Study of Lebrikizumab in Combination With Topical Corticosteroids in Patients With Atopic Dermatitis (AD) That Are Not Adequately Controlled With or Are Non-eligible for Cyclosporine: primary endpoint…
- AdvantageIndependent statistical analysis of Preference on the Feedback Mechanisms of Dose Delivery Confirmation With the Breezhaler® Device Compared to the Ellipta® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD): primary endpoint…
- ADVISEIndependent statistical analysis of A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Advisor HD Grid Observational Study: Complete Statistical AnalysisIndependent statistical analysis of Advisor HD Grid Observational Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03733392).
- AEGEANIndependent statistical analysis of Assessment of an Education and Guidance Programme for Eliquis Adherence in Non-Valvular Atrial Fibrillation (AEGEAN): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- AEGiSIndependent statistical analysis of Pre-exposure Prophylaxis (PrEP) Adherence Enhancement Guided by iTAB and Drug Levels for Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- AEROBICIndependent statistical analysis of Acute Exercise and the Cerebral Metabolic Response in Aging and Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- AESOPS-T1Independent statistical analysis of Application of Economics & Social Psychology to Improve Opioid Prescribing Safety Trial 1: EHR Nudges: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Afatinib in Subjects With Kidney Dysfunction: Complete Statistical AnalysisIndependent statistical analysis of Afatinib in Subjects With Kidney Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02096718).
- AFCAREIndependent statistical analysis of Feasibility Study to Improve AF Outcomes Using a Digital Application for CV Risk Reduction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- AFEQTIndependent statistical analysis of Colorectal Cancer Metastatic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01670721).
- AFFILIATEIndependent statistical analysis of Effects of Oral Sildenafil on Mortality in Adults With PAH: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02060487).
- AFFIRMComplete statistical analysis of the AFFIRM phase 3 trial of enzalutamide versus placebo in patients with castration-resistant prostate cancer previously treated with docetaxel-based chemotherapy, including overall survival, secondary time-to-event endpoints, response measures,…
- Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Aflibercept for Relapsed Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Aflibercept for Relapsed Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00437034).
- AFSPIndependent statistical analysis of Opiate Suicide Study in Patients With Major Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04116528).
- AGATE-1Independent statistical analysis of A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and…
- AGAVE-201Independent statistical analysis of A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Ageing and Health. Spanish Longitudinal Study: Complete Statistical AnalysisIndependent statistical analysis of Ageing and Health. Spanish Longitudinal Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03343886).
- Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain Hemorrhage: Complete Statistical AnalysisIndependent statistical analysis of Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain Hemorrhage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01530880).
- Aging and Estrogen on Cortical Function: Complete Statistical AnalysisIndependent statistical analysis of Aging and Estrogen on Cortical Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01268046).
- AGN-199201 for the Treatment of Erythema With Rosacea: Complete Statistical AnalysisIndependent statistical analysis of AGN-199201 for the Treatment of Erythema With Rosacea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01735201).
- AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis: Complete Statistical AnalysisIndependent statistical analysis of AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02161146).
- AGN-Cogni.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of AGN-Cogni.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- AGREEIndependent statistical analysis of MPC-004 for the Treatment of an Acute Gout Flare: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00506883).
- AHIndependent statistical analysis of A Research Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DUR-928 in Patients With Alcoholic Hepatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- AHAvsSIMIndependent statistical analysis of A Trial to Compare American Heart Association (AHA) and Simple (SIM)Method to Give Adenosine to Treat Supra-ventricular Tachycardia (SVT): primary endpoint results, effect estimate with confidence interval, sample-size…
- AHEADIndependent statistical analysis of Cardiovalve Transfemoral Mitral Valve System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03813524).
- AIDAIndependent statistical analysis of Adjusting Insulin Delivery to Activity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02299479).
- AiME – 13Independent statistical analysis of A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance…